Power Integrations Inc
Power Integrations Reports Third-Quarter Financial Results
Revenue increased five percent sequentially to $125.5 million; GAAP earnings were $0.32 per diluted share; non-GAAP earnings were $0.46 per diluted…
Source
From SEC EDGAR
156 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Relay Therapeutics, Inc.
Relay Therapeutics, Inc.
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Corpay, Inc.
Corpay Reports Third Quarter Financial Results
18% revenue growth, 11% organic revenue growth, and 32% adjusted EPS growth1
Tigo Energy, Inc.
Tigo Energy Reports Third Quarter 2026 Financial Results
Silvaco Group, Inc.
Silvaco Reports Third Quarter 2026 Financial Results
Won major new tier-1 FTCO customer and 4 tier-1 customers for Jivaro Pro in Q3
Mativ Holdings, Inc.
Mativ Announces Third Quarter 2026 Results
Ascent Industries Co.
Ascent Industries Reports Third Quarter 2026 Results; Year-Over-Year Net Sales Increase 37.8%, Including 26.3% Growth in Sales Excluding the Midwest Graphic Sales Acquisition; Adjusted EBITDA Improves by $2.1 Million
Sequentially, net sales increased 5.7%, gross profit increased 28.3% and
Veracyte, Inc.
Veracyte Announces Third Quarter 2026 Financial Results
Grew total revenue to $151.8 million and testing revenue to $146.4 million, representing 15% year-over-year growth
Vir Biotechnology, Inc.
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2026 Financial Results
- Topline data from pivotal Phase 3 ECLIPSE 1 trial expected in the fourth quarter of 2026
American Homes 4 Rent, L.P.
American Homes 4 Rent, L.P.
AMH Reports Third Quarter 2026 Financial and Operating Results
ThredUp Inc.
ThredUp Announces Third Quarter 2026 Results
•Quarterly revenue of $88.2 million, representing an increase of 7% year-over-year
Outset Medical, Inc.
Outset Medical Reports Third Quarter 2026 Results
Ionic Digital Inc.
Ionic Digital Announces Third Quarter 2026 Results
Received provisional Batch Zero Baseload Pathway (b) classification from ERCOT in September 2026 for 466 gross MW large-load request
Niagen Bioscience, Inc.
Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results
Launched Niagen™ Plus Niagen™ Liquid At-Home Injections
Acadia Pharmaceuticals Inc
Acadia Pharmaceuticals Reports Third Quarter 2026 Financial Results
- Third quarter GAAP total revenues of $342 million, up 22% year-over-year as compared to non-GAAP adjusted total revenues